Internal Medicine, Hematology & Oncology · Jonesboro, AR
NPI
1124231816
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4808 E Johnson Ave, Hem/Onc Dept.
Jonesboro, AR, 72401
Phone (870) 936-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
1,466 services
Medicare patients, 2024
522
Average age 74
Drug cost, 2024
$5.1M
2,837 prescriptions
Company payments, 2025
$1,364
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott A Dorroh was code 99214 (office e&m - established), 743 times for 248 patients. In total Scott A Dorroh billed 1,466 services in 15 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 743 | 248 | $60.04 | $45K |
| 99213 Office E&M - Established | Facility | 330 | 261 | $39.16 | $13K |
| 99205 Office E&M - New | Facility | 86 | 86 | $111.30 | $9,572 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 85 | 74 | $7.23 | $614 |
| 99223 Hospital E&M - Initial | Facility | 70 | 68 | $119.03 | $8,332 |
| 99222 Hospital E&M - Initial | Facility | 48 | 46 | $90.70 | $4,354 |
| 99215 Office E&M - Established | Facility | 40 | 31 | $90.89 | $3,636 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 23 | $56.57 | $1,923 |
By year: 2022 $111K for 1,548 services; 2023 $107K for 1,530 services; 2024 $87K for 1,466 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott A Dorroh prescribed most often to Medicare patients was Anastrozole, with 322 prescriptions and refills. In total Scott A Dorroh wrote 2,837 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 322 | 547 | 67 | $3,828 |
| Ondansetron Odt Ondansetron | 223 | 223 | 136 | $3,560 |
| Promethazine Hcl Generic | 159 | 159 | 92 | $1,187 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 150 | 150 | 49 | $5,658 |
| Hydroxyurea Generic | 146 | 193 | 21 | $2,712 |
| Xtandi Enzalutamide | 101 | 101 | 15 | $1.4M |
| Oxycodone Hcl Generic | 82 | 82 | 33 | $1,408 |
| Eliquis Apixaban | 75 | 82 | 15 | $49K |
| Prednisone Generic | 74 | 88 | 29 | $282 |
| Potassium Chloride Generic | 72 | 103 | 29 | $1,631 |
| Acyclovir Generic | 64 | 76 | 12 | $509 |
| Levothyroxine Sodium Generic | 63 | 79 | 13 | $350 |
| Sertraline Hcl Generic | 59 | 79 | 15 | $264 |
| Amlodipine Besylate Generic | 45 | 63 | 12 | $246 |
| Tramadol Hcl Generic | 44 | 44 | Under 11 | $620 |
Brand drugs: - claims; generic drugs: 2,379 claims; opioid claims: 381.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott A Dorroh $1,364 ($1,364 in general payments such as food, travel and fees) from 32 companies. The largest payer was Novartis Pharmaceuticals Corporation with $181.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $181 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $105 |
| Pfizer Inc. PFE | 6 | $95.75 |
| Merck Sharp & Dohme LLC MRK | 5 | $87.48 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $80.42 |
| Exelixis Inc. EXEL | 4 | $65.06 |
| Janssen Biotech, Inc. JNJ | 3 | $59.77 |
| Incyte Corporation INCY | 3 | $59.18 |
| Abbvie Inc. ABBV | 3 | $56.62 |
| Daiichi Sankyo Inc. 4568.T | 2 | $50.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.